Correspondence on Letter regarding "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study"

Affiliations

¹ Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
² Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
³ Department of Advanced Metabolic Hepatology, Osaka University, Graduate School of Medicine, Osaka, Japan.

Hideki Fujii et al. Clin Mol Hepatol. 2024 Apr.

. 2024 Apr;30(2):281-283.

doi: 10.3350/cmh.2024.0214. Epub 2024 Apr 1.

¹ Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
² Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
³ Department of Advanced Metabolic Hepatology, Osaka University, Graduate School of Medicine, Osaka, Japan.

No abstract available

Keywords: Cardiometabolic criteria; Cardiovascular disease; Liver biopsy.

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences.
Oh JH, Jun DW. Oh JH, et al. Clin Mol Hepatol. 2024 Apr;30(2):168-170. doi: 10.3350/cmh.2024.0140. Epub 2024 Mar 5. Clin Mol Hepatol. 2024. PMID: 38439189 Free PMC article. No abstract available.
Reply to correspondence on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study".
Yoon EL, Jun DW. Yoon EL, et al. Clin Mol Hepatol. 2024 Oct;30(4):1033-1034. doi: 10.3350/cmh.2024.0360. Epub 2024 May 20. Clin Mol Hepatol. 2024. PMID: 38768963 Free PMC article. No abstract available.

1. Iwaki M, Fujii H, Hayashi H, Toyoda H, Oeda S, Hyogo H, et al. Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study. Clin Mol Hepatol. 2024;30:225–234. - PMC - PubMed
1. Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, et al. Clinical outcomes in biopsy-proven nonalcoholic fatty liver disease patients: A multicenter registry-based cohort study. Clin Gastroenterol Hepatol. 2023;21:370–379. - PubMed
1. Oh JH, Jun DW. Clinical impact of five cardiometabolic risk factors in MALSD: Insights into regional and ethnic differences. Clin Mol Hepatol. 2024;30:168–170. - PMC - PubMed
1. Arafa A, Kashima R, Matsumoto C, Kokubo Y. Fatty liver index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The suita study. J Stroke Cerebrovasc Dis. 2024;33:107495. - PubMed
1. Leung JC, Loong TC, Wei JL, Wong GL, Chan AW, Choi PC, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology. 2017;65:54–64. - PubMed